Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


30.01.2017

11 Acta Cytol
1 Am J Dermatopathol
3 Anticancer Res
1 APMIS
6 Asian Pac J Cancer Prev
1 Biologicals
1 Biomarkers
2 Biomed Pharmacother
1 Biomed Res Int
1 Biosens Bioelectron
1 BJOG
1 BMC Cancer
1 BMC Med Res Methodol
1 BMC Public Health
1 BMJ Support Palliat Care
1 Brachytherapy
1 Bull Cancer
3 Cancer
1 Cancer Biother Radiopharm
1 Cancer Nurs
1 Crit Rev Oncol Hematol
1 Diagn Pathol
1 Dis Mon
1 Eur J Public Health
1 Exp Ther Med
1 Genet Mol Res
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Health Qual Life Outcomes
1 Int Braz J Urol
1 Int J Cancer
4 Int J Gynecol Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Cancer Surviv
3 J Contemp Brachytherapy
1 J Obstet Gynaecol Res
1 Mol Diagn Ther
1 Nature
2 Oncol Lett
1 Oncology
1 Oncotarget
2 PLoS One
1 Pol J Pathol
1 Protein Cell
1 Radiat Res
1 Radiol Med
1 Sci Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. VARGAS H, Sanchez JP, Guerrero ML, Ortiz LT, et al
    Type-Specific Identification of Genital Human Papillomavirus Infection in Women with Cytological Abnormality.
    Acta Cytol. 2016;60:211-6.
    PubMed     Text format     Abstract available

  2. SCHWOCK J, Ko HM, Dube V, Rouzbahman M, et al
    Stratified Mucin-Producing Intraepithelial Lesion of the Cervix: Subtle Features Not to Be Missed.
    Acta Cytol. 2016;60:225-31.
    PubMed     Text format     Abstract available

  3. DIAZ DEL ARCO C, Sanabria Montoro MC, Garcia Lopez D, Rodriguez Escudero E, et al
    Clinical Relevance of ASC-H Cytologies: Experience in a Single Tertiary Hospital.
    Acta Cytol. 2016;60:217-24.
    PubMed     Text format     Abstract available

  4. MARCOS LOPES AC, Campaner AB, Henrique LQ
    Prevalence of High-Grade Intraepithelial Neoplasia in Patients with Cytology Presenting Atypical Squamous Cells of Undetermined Significance.
    Acta Cytol. 2016;60:139-44.
    PubMed     Text format     Abstract available

  5. PLACIDI A, Capparucci P, Di Luzio A, Manca G, et al
    Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.
    Acta Cytol. 2016;60:458-464.
    PubMed     Text format     Abstract available

  6. BIBBO M, Wang ZX, Jones K, Solomides C, et al
    Review of Cytology Practice at Thomas Jefferson University Hospital before and after High-Risk Human Papillomavirus Testing.
    Acta Cytol. 2016;60:534-539.
    PubMed     Text format     Abstract available

  7. BERGERON C, von Knebel Doeberitz M
    The Role of Cytology in the 21st Century: The Integration of Cells and Molecules.
    Acta Cytol. 2016;60:540-542.
    PubMed     Text format     Abstract available

  8. LONGATTO-FILHO A
    The Role of Gynecological Cytology in the Era of Molecular Testing.
    Acta Cytol. 2016;60:499-500.
    PubMed     Text format    

  9. HUI Y, Hansen K, Murthy J, Chau D, et al
    Relevance of the Pap Test: A Report of HPV-DNA Test-Negative High-Grade Squamous Intraepithelial Lesions of the Female Lower Genital Tract.
    Acta Cytol. 2016;60:445-450.
    PubMed     Text format     Abstract available

  10. SUGIYAMA Y, Sasaki H, Komatsu K, Yabushita R, et al
    A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
    Acta Cytol. 2016;60:451-457.
    PubMed     Text format     Abstract available

  11. VALENTINE K, Vanden Broeck D, Benoy I, Truyens M, et al
    Cytology at the Time of HPV: Some Things to Think about when Discussing HPV.
    Acta Cytol. 2016;60:527-533.
    PubMed     Text format     Abstract available


    Am J Dermatopathol

  12. MICHAL M, Michal M, Miesbauerova M, Hercogova J, et al
    Penile Analogue of Stratified Mucin-Producing Intraepithelial Lesion of the Cervix: The First Described Case. A Diagnostic Pitfall.
    Am J Dermatopathol. 2016;38:e64-7.
    PubMed     Text format     Abstract available


    Anticancer Res

  13. GUI H, Guo XR, Fang J, Ma SN, et al
    The Tumor-promoting Effects of FAM92A1-289 in Cervical Carcinoma Cells.
    Anticancer Res. 2016;36:5197-5204.
    PubMed     Text format     Abstract available

  14. HILAL Z, Hartmann F, Dogan A, Cetin C, et al
    Lymphoma of the Cervix: Case Report and Review of the Literature.
    Anticancer Res. 2016;36:4931-40.
    PubMed     Text format     Abstract available

  15. NAKAMURA K, Nakayama K, Ishikawa M, Katagiri H, et al
    High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma.
    Anticancer Res. 2016;36:2933-8.
    PubMed     Text format     Abstract available


    APMIS

  16. PARK JS, Shin S, Kim EC, Kim JE, et al
    Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
    APMIS. 2016;124:950-957.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  17. MALEERAT P, Chumworathayi B, Kietpeerakool C, Luanratanakorn S, et al
    Post-Loop Electrosurgical Excision Procedure Complications in Srinagarind Hospital.
    Asian Pac J Cancer Prev. 2016;17:2211-5.
    PubMed     Text format     Abstract available

  18. KITTISIAM T, Tangjitgamol S, Chaowawanit W, Khunnarong J, et al
    Knowledge and Attitudes of Bangkok Metropolitan Women towards HPV and Self-Sampled HPV Testing.
    Asian Pac J Cancer Prev. 2016;17:2445-51.
    PubMed     Text format     Abstract available

  19. TANGJITGAMOL S, Kantathavorn N, Kittisiam T, Chaowawanit W, et al
    Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
    Asian Pac J Cancer Prev. 2016;17:3147-53.
    PubMed     Text format     Abstract available

  20. SENOL T, Polat M, Ozkaya E, Karateke A, et al
    Comparison of Two Step LEEP and Cold Conisation For Cervical Intraepithelial Lesions to Decrease Positive Surgical Margins.
    Asian Pac J Cancer Prev. 2016;17:3317-20.
    PubMed     Text format     Abstract available

  21. DE ABREU AL, Gimenes F, Malaguti N, Pereira MW, et al
    Detection of Human Papillomavirus among Women with Atypical Squamous Cells of Undetermined Significance Referred to Colposcopy: Implications for Clinical Management in Low and MiddleIncome Countries.
    Asian Pac J Cancer Prev. 2016;17:3637-41.
    PubMed     Text format     Abstract available

  22. HENG S, Sirichaisutdhikorn D
    Incidence of High Grade Squamous Intraepithelial Lesions in Patients with Atypical Squamous Cells of Undetermined Significance Papanicolaou Smears at Naresuan University Hospital.
    Asian Pac J Cancer Prev. 2016;17:2411-4.
    PubMed     Text format     Abstract available


    Biologicals

  23. STAMENKOVIC M, Knezevic A, Knezevic I, Kuzmanovic I, et al
    High-risk human papilloma virus genotypes in cervical carcinoma of Serbian women: Distribution and association with pathohistological findings.
    Biologicals. 2016;44:412-6.
    PubMed     Text format     Abstract available


    Biomarkers

  24. SINGHAL P, Sharma U, Hussain S, Nag A, et al
    Identification of genetic variants in TNF receptor 2 which are associated with the development of cervical carcinoma.
    Biomarkers. 2016;21:665-72.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  25. KUMAR D, Basu S, Parija L, Rout D, et al
    Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells.
    Biomed Pharmacother. 2016;81:31-7.
    PubMed     Text format     Abstract available

  26. SHARMA G, Rana NK, Singh P, Dubey P, et al
    p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells.
    Biomed Pharmacother. 2017;88:218-231.
    PubMed     Text format     Abstract available


    Biomed Res Int

  27. KIM TS, Lim MS, Hong YJ, Hwang SM, et al
    Significance of "Not Detected but Amplified" Results by Real-Time PCR Method for HPV DNA Detection.
    Biomed Res Int. 2016;2016:5170419.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  28. BARTOSIK M, Durikova H, Vojtesek B, Anton M, et al
    Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA.
    Biosens Bioelectron. 2016;83:300-5.
    PubMed     Text format     Abstract available


    BJOG

  29. POMEL C, Martinez A, Bourgin C, Beguinot M, et al
    Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis.
    BJOG. 2017 Jan 27. doi: 10.1111/1471-0528.14492.
    PubMed     Text format     Abstract available


    BMC Cancer

  30. GUERRERO-FLORES H, Apresa-Garcia T, Garay-Villar O, Sanchez-Perez A, et al
    A non-invasive tool for detecting cervical cancer odor by trained scent dogs.
    BMC Cancer. 2017;17:79.
    PubMed     Text format     Abstract available


    BMC Med Res Methodol

  31. TAX C, Steenbergen ME, Zusterzeel PL, Bekkers RL, et al
    Measuring health-related quality of life in cervical cancer patients: a systematic review of the most used questionnaires and their validity.
    BMC Med Res Methodol. 2017;17:15.
    PubMed     Text format     Abstract available


    BMC Public Health

  32. XIE Y, Tan X, Shao H, Liu Q, et al
    VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
    BMC Public Health. 2017;17:118.
    PubMed     Text format     Abstract available


    BMJ Support Palliat Care

  33. CHIARULLI P, Hebert RS
    Premature diagnostic closure in palliative medicine.
    BMJ Support Palliat Care. 2016;6:151-2.
    PubMed     Text format    


    Brachytherapy

  34. MAYADEV J, Viswanathan A, Liu Y, Li CS, et al
    American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
    Brachytherapy. 2017;16:22-43.
    PubMed     Text format     Abstract available


    Bull Cancer

  35. NAHET A, Boublenza L, Hassaine H, Masdoua N, et al
    [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
    Bull Cancer. 2016;103:455-60.
    PubMed     Text format     Abstract available


    Cancer

  36. BRAR H, Hogen L, Covens A
    Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30509.
    PubMed     Text format     Abstract available

  37. DALTON HJ, Farley JH
    Racial disparities in cervical cancer: Worse than we thought.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30501.
    PubMed     Text format    

  38. BEAVIS AL, Gravitt PE, Rositch AF
    Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30507.
    PubMed     Text format     Abstract available


    Cancer Biother Radiopharm

  39. PANICH T, Tragoolpua K, Pata S, Tayapiwatana C, et al
    Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
    Cancer Biother Radiopharm. 2017 Jan 24. doi: 10.1089/cbr.2016.2126.
    PubMed     Text format     Abstract available


    Cancer Nurs

  40. WONG EL, Cheung AW, Huang F, Chor JS, et al
    Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Cancer Nurs. 2017 Jan 20. doi: 10.1097/NCC.0000000000000462.
    PubMed     Text format     Abstract available


    Crit Rev Oncol Hematol

  41. ANGIOLI R, Lopez S, Aloisi A, Terranova C, et al
    Ten years of HPV vaccines: State of art and controversies.
    Crit Rev Oncol Hematol. 2016;102:65-72.
    PubMed     Text format     Abstract available


    Diagn Pathol

  42. CHEN Y, Wang H, Lin W, Shuai P, et al
    ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
    Diagn Pathol. 2017;12:12.
    PubMed     Text format     Abstract available


    Dis Mon

  43. HUTTER JN, Decker CF
    Human papillomavirus infection.
    Dis Mon. 2016;62:294-300.
    PubMed     Text format    


    Eur J Public Health

  44. VINCERZEVSKIENE I, Jasilionis D, Austys D, Stukas R, et al
    Education predicts cervical cancer survival: a Lithuanian cohort study.
    Eur J Public Health. 2017 Jan 23. pii: ckw261. doi: 10.1093.
    PubMed     Text format     Abstract available


    Exp Ther Med

  45. WANG Y, Zhang X, Miao F, Cao Y, et al
    Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer.
    Exp Ther Med. 2016;12:3699-3705.
    PubMed     Text format     Abstract available


    Genet Mol Res

  46. FENG H, Sui L, Du M, Wang Q, et al
    Meta-analysis of TP73 polymorphism and cervical cancer.
    Genet Mol Res. 2017;16.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  47. LEE YJ, Kim DY, Lee SW, Park JY, et al
    A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Gynecol Oncol. 2017 Jan 17. pii: S0090-8258(17)30001.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  48. PEREIRA E, Cooper HH, Zelaya PG, Creasman W, et al
    Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting.
    Gynecol Oncol Rep. 2016;19:50-52.
    PubMed     Text format     Abstract available


    Health Qual Life Outcomes

  49. OCK M, Park JY, Son WS, Lee HJ, et al
    Estimation of utility weights for human papilloma virus-related health states according to disease severity.
    Health Qual Life Outcomes. 2016;14:163.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  50. GOLDFARB RA, Fan Y, Jarosek S, Elliott SP, et al
    The burden of chronic ureteral stenting in cervical cancer survivors.
    Int Braz J Urol. 2017;43:104-111.
    PubMed     Text format     Abstract available


    Int J Cancer

  51. RODRIGUEZ AC, Avila C, Herrero R, Hildesheim A, et al
    Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30614.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  52. YANG K, Park W, Huh SJ, Park BK, et al
    Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000909.
    PubMed     Text format     Abstract available

  53. KIM M, Suh DH, Kim K, Lee HJ, et al
    Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:332-338.
    PubMed     Text format     Abstract available

  54. NEGRAO MV, Lima JM, Silva SC, Diz MD, et al
    Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
    Int J Gynecol Cancer. 2017 Jan 19. doi: 10.1097/IGC.0000000000000914.
    PubMed     Text format     Abstract available

  55. BOGANI G, Ditto A, Martinelli F, Signorelli M, et al
    Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000902.
    PubMed     Text format     Abstract available


    Int J Oncol

  56. ZHOU X, Yue Y, Wang R, Gong B, et al
    MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
    Int J Oncol. 2017 Jan 19. doi: 10.3892/ijo.2017.3857.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  57. MELL LK, Sirak I, Wei L, Tarnawski R, et al
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Int J Radiat Oncol Biol Phys. 2017;97:536-545.
    PubMed     Text format     Abstract available


    J Cancer Surviv

  58. TSENG OL, Spinelli JJ, Dawes M, McBride ML, et al
    Cervical cancer screening for survivors diagnosed with cancer before age 25.
    J Cancer Surviv. 2017 Jan 27. doi: 10.1007/s11764-017-0598.
    PubMed     Text format     Abstract available


    J Contemp Brachytherapy

  59. PERRUCCI E, Lancellotta V, Benedetto MD, Palumbo I, et al
    Encrusted cystitis after definitive radiotherapy for cervical cancer: a case report.
    J Contemp Brachytherapy. 2016;8:541-543.
    PubMed     Text format     Abstract available

  60. KUO HC, Mehta KJ, Yaparpalvi R, Shankar V, et al
    Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy.
    J Contemp Brachytherapy. 2016;8:525-532.
    PubMed     Text format     Abstract available

  61. OTTER S, Franklin A, Ajaz M, Stewart A, et al
    Improving the efficiency of image guided brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2016;8:557-565.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  62. YOSHIZAWA E, Koiwai K, Ina H, Fukazawa A, et al
    Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases.
    J Obstet Gynaecol Res. 2017 Jan 26. doi: 10.1111/jog.13259.
    PubMed     Text format     Abstract available


    Mol Diagn Ther

  63. LUTKOWSKA A, Roszak A, Lianeri M, Sowinska A, et al
    Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression.
    Mol Diagn Ther. 2017 Jan 25. doi: 10.1007/s40291-017-0256.
    PubMed     Text format     Abstract available


    Nature


  64. Integrated genomic and molecular characterization of cervical cancer.
    Nature. 2017 Jan 23. doi: 10.1038/nature21386.
    PubMed     Text format     Abstract available


    Oncol Lett

  65. YANG CX, Zhang SM, Li J, Yang B, et al
    MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting beta-catenin.
    Oncol Lett. 2016;12:4983-4990.
    PubMed     Text format     Abstract available

  66. YAMAUCHI M, Fukuda T, Wada T, Kawanishi M, et al
    Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Oncol Lett. 2016;12:5183-5189.
    PubMed     Text format     Abstract available


    Oncology

  67. MISHRA GA, Pimple SA, Shastri SS
    Prevention of Cervix Cancer in India.
    Oncology. 2016;91 Suppl 1:1-7.
    PubMed     Text format     Abstract available


    Oncotarget

  68. LI Y, Zhang Z, Xiao Z, Lin Y, et al
    Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Oncotarget. 2017 Jan 19. doi: 10.18632/oncotarget.14738.
    PubMed     Text format     Abstract available


    PLoS One

  69. ACERA A, Manresa JM, Rodriguez D, Rodriguez A, et al
    Increasing Cervical Cancer Screening Coverage: A Randomised, Community-Based Clinical Trial.
    PLoS One. 2017;12:e0170371.
    PubMed     Text format     Abstract available

  70. RAIFU AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, et al
    Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician.
    PLoS One. 2017;12:e0170631.
    PubMed     Text format     Abstract available


    Pol J Pathol

  71. MASUKO S, Ikura Y, Kato H, Iwai Y, et al
    Blue nevus presenting as an endocervical polyp.
    Pol J Pathol. 2016;67:191-4.
    PubMed     Text format    


    Protein Cell

  72. ZHAO KN, Zhang L, Qu J
    Dr. Jian Zhou: The great inventor of cervical cancer vaccine.
    Protein Cell. 2017 Jan 20. doi: 10.1007/s13238-016-0358.
    PubMed     Text format    


    Radiat Res

  73. GILBERT ES, Curtis RE, Hauptmann M, Kleinerman RA, et al
    Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.
    Radiat Res. 2017 Jan 24. doi: 10.1667/RR14453.
    PubMed     Text format     Abstract available


    Radiol Med

  74. STECCO A, Buemi F, Cassara A, Matheoud R, et al
    Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Radiol Med. 2016;121:537-45.
    PubMed     Text format     Abstract available


    Sci Rep

  75. LI X, Huang K, Zhang Q, Zhou J, et al
    Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.
    Sci Rep. 2017;7:41103.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: